Oxidative stress and the pathogenesis of alzheimer's disease

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Zhao, Yan ^a   Zhao, Baolu ^b  

^a HARBIN INSTITUTE OF TECHNOLOGY   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER'S DISEASE; COGNITIVE FUNCTIONS; MITOCHONDRIA DYSFUNCTIONS; MOLECULAR EVENTS; NEUROFIBRILLARY TANGLES; REACTIVE OXYGEN SPECIES; REDOX BALANCES; SENILE PLAQUES;

FREE RADICALS; NEURODEGENERATIVE DISEASES;

OXIDATIVE STRESS;

AMYLOID BETA PROTEIN; ASCORBIC ACID; BETA SECRETASE 1; COPPER; FREE RADICAL; IRON; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; REACTIVE OXYGEN METABOLITE; TAU PROTEIN; TRANSITION ELEMENT; ZINC; ZINC TRANSPORTER;

ALZHEIMER DISEASE; AUTOOXIDATION; COGNITION; DISEASE COURSE; HOMEOSTASIS; HUMAN; MEMORY; MENTAL DETERIORATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN POLYMERIZATION; REVIEW; SENILE PLAQUE; METABOLISM; PHYSIOLOGY;

ALZHEIMER DISEASE; HUMANS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84881525560     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/316523     Document Type: Review

References (136)

1. Querfurth H. W., LaFerla F. M., Alzheimer's disease. The New England Journal of Medicine 2010 362 4 329 344 2-s2.0-75449102536 10.1056/NEJMra0909142
2. 2010 Alzheimer's disease facts and figures. Alzheimer's & Dementia 2010 6 158 194
3. Dong M.-J., Peng B., Lin X.-T., Zhao J., Zhou Y.-R., Wang R.-H., The prevalence of dementia in the People's Republic of China: a systematic analysis of 1980-2004 studies. Age and Ageing 2007 36 6 619 624 2-s2.0-37149011087 10.1093/ageing/afm128 (Pubitemid 350258969)
4. Ferri C. P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., Jorm A., Mathers C., Menezes P. R., Rimmer E., Scazufca M., Global prevalence of dementia: a Delphi consensus study. The Lancet 2005 366 9503 2112 2117 2-s2.0-29144508843 10.1016/S0140-6736(05)67889-0 (Pubitemid 41797645)
5. Kalaria R. N., Maestre G. E., Arizaga R., Friedland R. P., Galasko D., Hall K., Luchsinger J. A., Ogunniyi A., Perry E. K., Potocnik F., Prince M., Stewart R., Wimo A., Zhang Z.-X., Antuono P., Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. The Lancet Neurology 2008 7 9 812 826 2-s2.0-49049122193 10.1016/S1474-4422(08) 70169-8
6. Goedert M., Spillantini M. G., A century of Alzheimer's disease. Science 2006 314 5800 777 781 2-s2.0-33750705653 10.1126/science.1132814 (Pubitemid 44706636)
7. Praticò D., Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends in Pharmacological Sciences 2008 29 12 609 615 2-s2.0-56349145099 10.1016/j.tips.2008.09.001
8. Nunomura A., Perry G., Pappolla M. A., Wade R., Hirai K., Chiba S., Smith M. A., RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. Journal of Neuroscience 1999 19 6 1959 1964 2-s2.0-0033559462 (Pubitemid 29133374)
9. Gabbita S. P., Lovell M. A., Markesbery W. R., Increased nuclear DNA oxidation in the brain in Alzheimer' s disease. Journal of Neurochemistry 1998 71 5 2034 2040 2-s2.0-0031754202 (Pubitemid 28491559)
10. Mecocci P., MacGarvey U., Beal M. F., Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Annals of Neurology 1994 36 5 747 751 2-s2.0-0028152717 10.1002/ana.410360510 (Pubitemid 24337634)
11. Butterfield D. A., Kanski J., Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mechanisms of Ageing and Development 2001 122 9 945 962 2-s2.0-0035880007 10.1016/S0047-6374(01)00249-4 (Pubitemid 32441616)
12. Beal M. F., Oxidatively modified proteins in aging and disease. Free Radical Biology and Medicine 2002 32 9 797 803 2-s2.0-0036570159 10.1016/S0891-5849(02)00780-3 (Pubitemid 34439250)
13. Praticò D., Sung S., Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. Journal of Alzheimer's Disease 2004 6 2 171 175 2-s2.0-2342420034 (Pubitemid 38560253)
14. Lovell M. A., Ehmann W. D., Butler S. M., Markesbery W. R., Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 1995 45 8 1594 1601 2-s2.0-0029073455
15. Markesbery W. R., Lovell M. A., Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiology of Aging 1998 19 1 33 36 2-s2.0-0031980065 10.1016/S0197-4580(98)00009-8 (Pubitemid 28167792)
16. Williams T. I., Lynn B. C., Markesbery W. R., Lovell M. A., Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiology of Aging 2006 27 8 1094 1099 2-s2.0-33744935554 10.1016/j.neurobiolaging.2005.06.004 (Pubitemid 43850642)
17. Marcus D. L., Thomas C., Rodriguez C., Simberkoff K., Tsai J. S., Strafaci J. A., Freedman M. L., Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Experimental Neurology 1998 150 1 40 44 2-s2.0-0032031780 10.1006/exnr.1997.6750 (Pubitemid 28146421)
18. Omar R. A., Chyan Y.-J., Andorn A. C., Poeggeler B., Robakis N. K., Pappolla M. A., Increased expression but reduced activity of antioxidant enzymes in Alzheimer's disease. Journal of Alzheimer's Disease 1999 1 3 139 145 2-s2.0-0033302860
19. Furuta A., Price D. L., Pardo C. A., Troncoso J. C., Xu Z.-S., Taniguchi N., Martin L. J., Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. American Journal of Pathology 1995 146 2 357 367 2-s2.0-0028830958
20. Padurariu M., Ciobica A., Hritcu L., Stoica B., Bild W., Stefanescu C., Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neuroscience Letters 2010 469 1 6 10 2-s2.0-72649096229 10.1016/j.neulet.2009.11.033
21. Ansari M. A., Scheff S. W., Oxidative stress in the progression of alzheimer disease in the frontal cortex. Journal of Neuropathology and Experimental Neurology 2010 69 2 155 167 2-s2.0-75949121583 10.1097/NEN. 0b013e3181cb5af4
22. Steiner H., Uncovering gamma-secretase. Current Alzheimer Research 2004 1 3 175 181 2-s2.0-24144441879
23. Walsh D. M., Selkoe D. J., A β oligomers-a decade of discovery. Journal of Neurochemistry 2007 101 5 1172 1184 2-s2.0-34248190279 10.1111/j.1471-4159.2006.04426.x (Pubitemid 46718812)
24. Yankner B. A., Lu T., Amyloid β -protein toxicity and the pathogenesis of Alzheimer disease. Journal of Biological Chemistry 2009 284 8 4755 4759 2-s2.0-64149132721 10.1074/jbc.R800018200
25. Esler W. P., Wolfe M. S., A portrait of Alzheimer secretases-new features and familiar faces. Science 2001 293 5534 1449 1454 2-s2.0-0035943345 10.1126/science.1064638 (Pubitemid 32801541)
26. Roberson E. D., Mucke L., 100 Years and counting: prospects for defeating Alzheimer's disease. Science 2006 314 5800 781 784 2-s2.0-33750731675 10.1126/science.1132813 (Pubitemid 44706637)
27. Maccioni R. B., Muñoz J. P., Barbeito L., The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Archives of Medical Research 2001 32 5 367 381 2-s2.0-0034829801 10.1016/S0188-4409(01)00316-2 (Pubitemid 32918139)
28. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G., Correlative memory deficits, A β elevation, and amyloid plaques in transgenic mice. Science 1996 274 5284 99 102 2-s2.0-0029742199 10.1126/science.274.5284.99 (Pubitemid 26332733)
29. Mattson M. P., Cellular actions of β -amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiological Reviews 1997 77 4 1081 1132 2-s2.0-0030779677 (Pubitemid 27459580)
30. Behl C., Davis J. B., Lesley R., Schubert D., Hydrogen peroxide mediates amyloid β protein toxicity. Cell 1994 77 6 817 827 2-s2.0-0028233494 10.1016/0092-8674(94)90131-7 (Pubitemid 24187680)
31. Matsuoka Y., Picciano M., La Francois J., Duff K., Fibrillar β -amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease. Neuroscience 2001 104 3 609 613 2-s2.0-0035859221 10.1016/S0306- 4522(01)00115-4 (Pubitemid 32607413)
32. Smith M. A., Hirai K., Hsiao K., Pappolla M. A., Harris P. L. R., Siedlak S. L., Tabaton M., Perry G., Amyloid- β deposition in Alzheimer transgenic mice is associated with oxidative stress. Journal of Neurochemistry 1998 70 5 2212 2215 2-s2.0-0031981072 (Pubitemid 28207848)
33. Mohmmad Abdul H., Sultana R., Keller J. N., St. Clair D. K., Markesbery W. R., Butterfield D. A., Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid β -peptide (1-42), H and kainic acid: implications for Alzheimer's disease. Journal of Neurochemistry 2006 96 5 1322 1335 2-s2.0-33645106304 10.1111/j.1471-4159.2005.03647.x
34. Manczak M., Anekonda T. S., Henson E., Park B. S., Quinn J., Reddy P. H., Mitochondria are a direct site of A β accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Human Molecular Genetics 2006 15 9 1437 1449 2-s2.0-33646152108 10.1093/hmg/ddl066
35. Apelt J., Bigl M., Wunderlich P., Schliebs R., Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology. International Journal of Developmental Neuroscience 2004 22 7 475 484 2-s2.0-4744369310 10.1016/j.ijdevneu.2004.07.006 (Pubitemid 39311436)
36. De Felice F. G., Velasco P. T., Lambert M. P., Viola K., Fernandez S. J., Ferreira S. T., Klein W. L., A β oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. Journal of Biological Chemistry 2007 282 15 11590 11601 2-s2.0-34249672242 10.1074/jbc.M607483200 (Pubitemid 47100810)
37. Cole G. M., Teter B., Frautschy S. A., Neuroprotective effects of curcumin. Advances in Experimental Medicine and Biology 2007 595 197 212 2-s2.0-34347216379 10.1007/978-0-387-46401-5-8
38. Mandel S. A., Amit T., Kalfon L., Reznichenko L., Youdim M. B. H., Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. Journal of Nutrition 2008 138 8 2-s2.0-49449090948
39. Zhao Y., Zhao B., Natural antioxidants in prevention and management of Alzheimer's disease. Frontiers in Bioscience 2012 4 794 808
40. Smith J. V., Luo Y., Studies on molecular mechanisms of Ginkgo biloba extract. Applied Microbiology and Biotechnology 2004 64 4 465 472 2-s2.0-2542467819 10.1007/s00253-003-1527-9 (Pubitemid 38686154)
41. Li F., Calingasan N. Y., Yu F., Mauck W. M., Toidze M., Almeida C. G., Takahashi R. H., Carlson G. A., Beal M. F., Lin M. T., Gouras G. K., Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. Journal of Neurochemistry 2004 89 5 1308 1312 2-s2.0-2642544767 10.1111/j.1471-4159. 2004.02455.x (Pubitemid 38715849)
42. Nishida Y., Yokota T., Takahashi T., Uchihara T., Jishage K.-I., Mizusawa H., Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse. Biochemical and Biophysical Research Communications 2006 350 3 530 536 2-s2.0-33749648745 10.1016/j.bbrc.2006.09.083 (Pubitemid 44547880)
43. Lim G. P., Chu T., Yang F., Beech W., Frautschy S. A., Cole G. M., The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. Journal of Neuroscience 2001 21 21 8370 8377 2-s2.0-0035503597 (Pubitemid 33051435)
44. Dumont M., Wille E., Stack C., Calingasan N. Y., Beal M. F., Lin M. T., Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. The FASEB Journal 2009 23 8 2459 2466 2-s2.0-68849110235 10.1096/fj.09-132928
45. Murakami K., Murata N., Noda Y., Tahara S., Kaneko T., Kinoshita N., Hatsuta H., Murayama S., Barnham K. J., Irie K., Shirasawa T., Shimizu T., SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease. Journal of Biological Chemistry 2011 286 52 44557 44568 2-s2.0-84455161651 10.1074/jbc.M111.279208
46. Tamagno E., Bardini P., Obbili A., Vitali A., Borghi R., Zaccheo D., Pronzato M. A., Danni O., Smith M. A., Perry G., Tabaton M., Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiology of Disease 2002 10 3 279 288 2-s2.0-0036403838 10.1006/nbdi.2002.0515 (Pubitemid 35217581)
47. Oda A., Tamaoka A., Araki W., Oxidative stress up-regulates presenilin 1 in lipid rafts in neuronal cells. Journal of Neuroscience Research 2010 88 5 1137 1145 2-s2.0-77950131689 10.1002/jnr.22271
48. Yoo M.-H., Gu X., Xu X.-M., Kim J.-Y., Carlson B. A., Patterson A. D., Cai H., Gladyshev V. N., Hatfield D. L., Delineating the role of glutathione peroxidase 4 in protecting cells against lipid hydroperoxide damage and in alzheimer's disease. Antioxidants and Redox Signaling 2010 12 7 819 827 2-s2.0-77649262137 10.1089/ars.2009.2891
49. Chen L., Na R., Gu M., Richardson A., Ran Q., Lipid peroxidation up-regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in Alzheimer's disease. Journal of Neurochemistry 2008 107 1 197 207 2-s2.0-51849150799 10.1111/j.1471-4159.2008.05603.x
50. Quiroz-Baez R., Rojas E., Arias C., Oxidative stress promotes JNK-dependent amyloidogenic processing of normally expressed human APP by differential modification of α -, β-and γ -secretase expression. Neurochemistry International 2009 55 7 662 670 2-s2.0-69349091132 10.1016/j.neuint.2009.06.012
51. Tamagno E., Guglielmotto M., Aragno M., Borghi R., Autelli R., Giliberto L., Muraca G., Danni O., Zhu X., Smith M. A., Perry G., Jo D.-G., Mattson M. P., Tabaton M., Oxidative stress activates a positive feedback between the γ-and β -secretase cleavages of the β -amyloid precursor protein. Journal of Neurochemistry 2008 104 3 683 695 2-s2.0-38049098793 10.1111/j.1471-4159.2007.05072.x
52. Shen C., Chen Y., Liu H., Zhang K., Zhang T., Lin A., Jing N., Hydrogen peroxide promotes A β production through JNK-dependent activation of γ -secretase. Journal of Biological Chemistry 2008 283 25 17721 17730 2-s2.0-47749147258 10.1074/jbc.M800013200
53. Sambamurti K., Kinsey R., Maloney B., Ge Y.-W., Lahiri D. K., Gene structure and organization of the human β -secretase (BACE) promoter. The FASEB Journal 2004 18 9 1034 1036 2-s2.0-6944231363 10.1096/fj.03-1378fje (Pubitemid 39561516)
54. Zhu X., Raina A. K., Rottkamp C. A., Aliev G., Perry G., Boux H., Smith M. A., Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. Journal of Neurochemistry 2001 76 2 435 441 2-s2.0-0035142804 10.1046/j.1471-4159.2001. 00046.x (Pubitemid 32097021)
55. Zhu X., Ogawa O., Wang Y., Perry G., Smith M. A., JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease. Journal of Neurochemistry 2003 85 1 87 93 2-s2.0-0037380952 (Pubitemid 36389698)
56. Lagalwar S., Guillozet-Bongaarts A. L., Berry R. W., Binder L. I., Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease. Journal of Neuropathology and Experimental Neurology 2006 65 5 455 464 2-s2.0-33746282816 10.1097/01.jnen.0000229236.98124.d8 (Pubitemid 44297267)
57. Fukumoto H., Cheung B. S., Hyman B. T., Irizarry M. C., β -secretase protein and activity are increased in the neocortex in Alzheimer disease. Archives of Neurology 2002 59 9 1381 1389 2-s2.0-0036718272 10.1001/archneur.59. 9.1381 (Pubitemid 35014802)
58. Yang L.-B., Lindholm K., Yan R., Citron M., Xia W., Yang X.-L., Beach T., Sue L., Wong P., Price D., Li R., Shen Y., Elevated β -secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nature Medicine 2003 9 1 3 4 2-s2.0-0037236622 10.1038/nm0103-3 (Pubitemid 36098241)
59. Matsui T., Ingelsson M., Fukumoto H., Ramasamy K., Kowa H., Frosch M. P., Irizarry M. C., Hyman B. T., Expression of APP pathway mRNAs and proteins in Alzheimer's disease. Brain Research 2007 1161 1 116 123 2-s2.0-34447527687 10.1016/j.brainres.2007.05.050 (Pubitemid 47068429)
60. Yao M., Nguyen T.-V. V., Pike C. J., β -Amyloid-induced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w. Journal of Neuroscience 2005 25 5 1149 1158 2-s2.0-13944275183 10.1523/JNEUROSCI.4736-04.2005 (Pubitemid 40268956)
61. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E. K., Jones P. K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C. S., Petersen R. B., Smith M. A., Oxidative damage is the earliest event in Alzheimer disease. Journal of Neuropathology and Experimental Neurology 2001 60 8 759 767 2-s2.0-0034923434 (Pubitemid 32678256)
62. Nunomura A., Chiba S., Lippa C. F., Cras P., Kalaria R. N., Takeda A., Honda K., Smith M. A., Perry G., Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease. Neurobiology of Disease 2004 17 1 108 113 2-s2.0-4444302948 10.1016/j.nbd.2004.06.003 (Pubitemid 39209318)
63. Nunomura A., Tamaoki T., Tanaka K., Motohashi N., Nakamura M., Hayashi T., Yamaguchi H., Shimohama S., Lee H.-G., Zhu X., Smith M. A., Perry G., Intraneuronal amyloid β accumulation and oxidative damage to nucleic acids in Alzheimer disease. Neurobiology of Disease 2010 37 3 731 737 2-s2.0-75949101857 10.1016/j.nbd.2009.12.012
64. Nunomura A., Castellani R. J., Zhu X., Moreira P. I., Perry G., Smith M. A., Involvement of oxidative stress in Alzheimer disease. Journal of Neuropathology and Experimental Neurology 2006 65 7 631 641 2-s2.0-33747861696 10.1097/01.jnen.0000228136.58062.bf (Pubitemid 44297254)
65. Luo Y., Sunderland T., Roth G. S., Wolozin B., Physiological levels of β -amyloid peptide promote PC12 cell proliferation. Neuroscience Letters 1996 217 2-3 125 128 2-s2.0-0030592575 10.1016/0304-3940(96)13087-1 (Pubitemid 26358818)
66. Plant L. D., Boyle J. P., Smith I. F., Peers C., Pearson H. A., The production of amyloid β peptide is a critical requirement for the viability of central neurons. Journal of Neuroscience 2003 23 13 5531 5535 2-s2.0-0038045587 (Pubitemid 36807828)
67. Kontush A., Berndt C., Weber W., Akopyan V., Arlt S., Schippling S., Beisiegel U., Amyloid- β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma. Free Radical Biology and Medicine 2001 30 1 119 128 2-s2.0-0035178803 10.1016/S0891-5849(00)00458-5 (Pubitemid 32008095)
68. Puzzo D., Privitera L., Leznik E., Fà M., Staniszewski A., Palmeri A., Arancio O., Picomolar amyloid- β positively modulates synaptic plasticity and memory in hippocampus. Journal of Neuroscience 2008 28 53 14537 14545 2-s2.0-58149385218 10.1523/JNEUROSCI.2692-08.2008
69. Zou K., Gong J.-S., Yanagisawa K., Michikawa M., A novel function of monomeric amyloid β -protein serving as an antioxidant molecule against metal-induced oxidative damage. Journal of Neuroscience 2002 22 12 4833 4841 2-s2.0-0037096251 (Pubitemid 37465598)
70. Tan S., Sagara Y., Liu Y., Maher P., Schubert D., The regulation of reactive oxygen species production during programmed cell death. Journal of Cell Biology 1998 141 6 1423 1432 2-s2.0-0032526940 10.1083/jcb.141.6.1423 (Pubitemid 28289917)
71. Grivennikova V. G., Vinogradov A. D., Generation of superoxide by the mitochondrial Complex I. Biochimica et Biophysica Acta 2006 1757 5-6 553 561 2-s2.0-33745628757 10.1016/j.bbabio.2006.03.013 (Pubitemid 43993849)
72. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R. L., Atwood C. S., Johnson A. B., Kress Y., Vinters H. V., Tabaton M., Shimohama S., Cash A. D., Siedlak S. L., Harris P. L. R., Jones P. K., Petersen R. B., Perry G., Smith M. A., Mitochondrial abnormalities in Alzheimer's disease. Journal of Neuroscience 2001 21 9 3017 3023 2-s2.0-0035341254 (Pubitemid 32323483)
73. Zhu X., Perry G., Moreira P. I., Aliev G., Cash A. D., Hirai K., Smith M. A., Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. Journal of Alzheimer's Disease 2006 9 2 147 153 2-s2.0-33746089859 (Pubitemid 44078642)
74. Mutisya E. M., Bowling A. C., Beal M. F., Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. Journal of Neurochemistry 1994 63 6 2179 2184 2-s2.0-0028110234 (Pubitemid 24369993)
75. Caspersen C., Wang N., Yao J., Sosunov A., Chen X., Lustbader J. W., Xu H. W., Stern D., McKhann G., Yan S. D., Mitochondrial A β: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. The FASEB Journal 2005 19 14 2040 2041 2-s2.0-28744449206 10.1096/fj.05-3735fje (Pubitemid 41759758)
76. Rodrigues C. M. P., Solá S., Brito M. A., Brondino C. D., Brites D., Moura J. J. G., Amyloid β -peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate. Biochemical and Biophysical Research Communications 2001 281 2 468 474 2-s2.0-0034812181 10.1006/bbrc.2001.4370 (Pubitemid 32928179)
77. Casley C. S., Canevari L., Land J. M., Clark J. B., Sharpe M. A., β -Amyloid inhibits integrated mitochondrial respiration and key enzyme activities. Journal of Neurochemistry 2002 80 1 91 100 2-s2.0-0036272650 10.1046/j.0022-3042.2001.00681.x (Pubitemid 34614581)
78. Anantharaman M., Tangpong J., Keller J. N., Murphy M. P., Markesbery W. R., Kiningham K. K., St. Clair D. K., β -amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLh/NLh X PS-1 P264L/P264L double knock-in mouse model of Alzheimer's disease. American Journal of Pathology 2006 168 5 1608 1618 2-s2.0-33646534207 10.2353/ajpath.2006.051223
79. Rousset S., Alves-Guerra M.-C., Mozo J., Miroux B., Cassard-Doulcier A.-M., Bouillaud F., Ricquier D., The biology of mitochondrial uncoupling proteins. Diabetes 2004 53 1 S130 S135 2-s2.0-0842306477 (Pubitemid 38168705)
80. Echtay K. S., Mitochondrial uncoupling proteins-what is their physiological role? Free Radical Biology and Medicine 2007 43 10 1351 1371 2-s2.0-34948890043 10.1016/j.freeradbiomed.2007.08.011 (Pubitemid 47532367)
81. de la Monte S. M., Wands J. R., Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease. Journal of Alzheimer's Disease 2006 9 2 167 181 2-s2.0-33746238205 (Pubitemid 44088244)
82. Wu Z., Zhang J., Zhao B., Superoxide anion regulates the mitochondrial free ca2+ through uncoupling proteins. Antioxidants and Redox Signaling 2009 11 8 1805 1818 2-s2.0-67650254170 10.1089/ars.2009.2427
83. Schlief M. L., Gitlin J. D., Copper homeostasis in the CNS: a novel link between the NMDA receptor and copper homeostasis in the hippocampus. Molecular Neurobiology 2006 33 2 81 90 2-s2.0-33646856612 10.1385/MN:33:2:81 (Pubitemid 43780368)
84. Smart T. G., Hosie A. M., Miller P. S., Zn2+ ions: modulators of excitatory and inhibitory synaptic activity. Neuroscientist 2004 10 5 432 442 2-s2.0-4544236080 10.1177/1073858404263463 (Pubitemid 39244580)
85. Munoz P., Humeres A., Iron deficiency on neuronal function. Biometals 2012 25 4 825 835 10.1007/s10534-012-9550-x
86. Kenche V. B., Barnham K. J., Alzheimer's disease & metals: therapeutic opportunities. British Journal of Pharmacology 2011 163 2 211 219 2-s2.0-79954453376 10.1111/j.1476-5381.2011.01221.x
87. Deibel M. A., Ehmann W. D., Markesbery W. R., Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. Journal of the Neurological Sciences 1996 143 1-2 137 142 2-s2.0-0030297178 10.1016/S0022-510X(96)00203-1 (Pubitemid 26402800)
88. Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L., Markesbery W. R., Copper, iron and zinc in Alzheimer's disease senile plaques. Journal of the Neurological Sciences 1998 158 1 47 52 2-s2.0-0032507975 10.1016/S0022-510X(98)00092-6 (Pubitemid 28277534)
89. Lee J. Y., Mook-Jung I., Koh J. Y., Histochemically reactive zinc in plaques of the Swedish mutant beta-amyloid precursor protein transgenic mice. The Journal of Neuroscience 1999 19 11 RC10 2-s2.0-0033139740
90. Zhang J., Liu Q., Chen Q., Liu N.-Q., Li F.-L., Lu Z.-B., Qin C., Zhu H., Huang Y.-Y., He W., Zhao B.-L., Nicotine attenuates beta-amyloid-induced neurotoxicity by regulating metal homeostasis. The FASEB Journal 2006 20 8 1212 1214 2-s2.0-33745989544 10.1096/fj.05-5214fje (Pubitemid 44943875)
91. Curtain C. C., Ali F., Volitakis I., Cherny R. A., Norton R. S., Beyreuther K., Barrow C. J., Masters C. L., Bush A. I., Barnham K. J., Alzheimer's disease amyloid- β binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. Journal of Biological Chemistry 2001 276 23 20466 20473 2-s2.0-0035827681 10.1074/jbc.M100175200
92. Hesse L., Beher D., Masters C. L., Multhaup G., The β A4 amyloid precursor protein binding to copper. FEBS Letters 1994 349 1 109 116 2-s2.0-0028177269 10.1016/0014-5793(94)00658-X
93. Atwood C. S., Moir R. D., Huang X., Scarpa R. C., Bacarra N. M. E., Romano D. M., Hartshorn M. A., Tanzi R. E., Bush A. I., Dramatic aggregation of alzheimer by Cu(II) is induced by conditions representing physiological acidosis. Journal of Biological Chemistry 1998 273 21 12817 12826 2-s2.0-0032557425 10.1074/jbc.273.21.12817 (Pubitemid 28246837)
94. Bush A. I., Pettingell W. H., Multhaup G., Paradis M. D., Vonsattel J.-P., Gusella J. F., Beyreuther K., Masters C. L., Tanzi R. E., Rapid induction of Alzheimer A β amyloid formation by zinc. Science 1994 265 5177 1464 1467 2-s2.0-0027980901 (Pubitemid 24306803)
95. Strausak D., Mercer J. F. B., Dieter H. H., Stremmel W., Multhaup G., Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases. Brain Research Bulletin 2001 55 2 175 185 2-s2.0-0035872487 10.1016/S0361-9230(01)00454-3 (Pubitemid 32722157)
96. Bush A. I., Metal complexing agents as therapies for Alzheimer's disease. Neurobiology of Aging 2002 23 6 1031 1038 2-s2.0-0036860349 10.1016/S0197-4580(02)00120-3 (Pubitemid 35447784)
97. Opazo C., Huang X., Cherny R. A., Moir R. D., Roher A. E., White A. R., Cappai R., Masters C. L., Tanzi R. E., Inestrosa N. C., Bush A. I., Metalloenzyme-like activity of Alzheimer's disease β -amyloid: Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H Journal of Biological Chemistry 2002 277 43 40302 40308 2-s2.0-0037174856 10.1074/jbc.M206428200 (Pubitemid 35215603)
98. Huang X., Cuajungco M. P., Atwood C. S., Hartshorn M. A., Tyndall J. D. A., Hanson G. R., Stokes K. C., Leopold M., Multhaup G., Goldstein L. E., Scarpa R. C., Saunders A. J., Lim J., Moir R. D., Glabe C., Bowden E. F., Masters C. L., Fairlie D. P., Tanzi R. E., Bush A. I., Cu(II) potentiation of Alzheimer a β neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. Journal of Biological Chemistry 1999 274 52 37111 37116 2-s2.0-0033601338 10.1074/jbc.274.52.37111 (Pubitemid 30016785)
99. Huang X., Atwood C. S., Hartshorn M. A., Multhaup G., Goldstein L. E., Scarpa R. C., Cuajungco M. P., Gray D. N., Lim J., Moir R. D., Tanzi R. E., Bush A. I., The A β peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 1999 38 24 7609 7616 2-s2.0-0033564690 10.1021/bi990438f (Pubitemid 29289332)
100. Lynch T., Cherny R. A., Bush A. I., Oxidative processes in Alzheimer's disease: the role of A β -metal interactions. Experimental Gerontology 2000 35 4 445 451 2-s2.0-0034233474 10.1016/S0531-5565(00)00112-1 (Pubitemid 30665820)
101. Rottkamp C. A., Raina A. K., Zhu X., Gaier E., Bush A. I., Atwood C. S., Chevion M., Perry G., Smith M. A., Redox-active iron mediates amyloid- β toxicity. Free Radical Biology and Medicine 2001 30 4 447 450 2-s2.0-0035865905 10.1016/S0891-5849(00)00494-9 (Pubitemid 32155543)
102. Wan L., Nie G., Zhang J., Luo Y., Zhang P., Zhang Z., Zhao B., β -Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease. Free Radical Biology and Medicine 2011 50 1 122 129 2-s2.0-78650685650 10.1016/j. freeradbiomed.2010.10.707
103. Zheng W., Xin N., Chi Z.-H., Zhao B.-L., Zhang J., Li J.-Y., Wang Z.-Y., Divalent metal transporter 1 is involved in amyloid precursor protein processing and A β generation. The FASEB Journal 2009 23 12 4207 4217 2-s2.0-72749101173 10.1096/fj.09-135749
104. Rogers J. T., Randall J. D., Cahill C. M., Eder P. S., Huang X., Gunshin H., Leiter L., McPhee J., Sarang S. S., Utsuki T., Greig N. H., Lahiri D. K., Tanzi R. E., Bush A. I., Giordano T., Gullans S. R., An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript. Journal of Biological Chemistry 2002 277 47 45518 45528 2-s2.0-0347928847 10.1074/jbc.M207435200 (Pubitemid 36159162)
105. Borchardt T., Camakaris J., Cappai R., Masters C. L., Beyreuther K., Multhaup G., Copper inhibits β -amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion. Biochemical Journal 1999 344 2 461 467 2-s2.0-0033430087 10.1042/0264-6021:3440461 (Pubitemid 30011603)
106. Zhang L.-H., Wang X., Zheng Z.-H., Ren H., Stoltenberg M., Danscher G., Huang L., Rong M., Wang Z.-Y., Altered expression and distribution of zinc transporters in APP/PS1 transgenic mouse brain. Neurobiology of Aging 2010 31 1 74 87 2-s2.0-70449709313 10.1016/j.neurobiolaging.2008.02.018
107. Zhang L.-H., Wang X., Stoltenberg M., Danscher G., Huang L., Wang Z.-Y., Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain. Brain Research Bulletin 2008 77 1 55 60 2-s2.0-51749106579 10.1016/j.brainresbull.2008.03.014
108. Li H., Li F., Sun H., Qian Z. M., Membrane-inserted conformation of transmembrane domain 4 of divalent-metal transporter. Biochemical Journal 2003 372 3 757 766 2-s2.0-0038266898 10.1042/BJ20030075 (Pubitemid 36760389)
109. Barnham K. J., McKinstry W. J., Multhaup G., Galatis D., Morton C. J., Curtain C. C., Williamson N. A., White A. R., Hinds M. G., Norton R. S., Beyreuther K., Masters C. L., Parker M. W., Cappai R., Structure of the Alzheimer's disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis. Journal of Biological Chemistry 2003 278 19 17401 17407 2-s2.0-0037931743 10.1074/jbc.M300629200 (Pubitemid 36799626)
110. Maynard C. J., Cappai R., Volitakis I., Cherny R. A., White A. R., Beyreuther K., Masters C. L., Bush A. I., Li Q.-X., Overexpression of Alzheimer's disease amyloid- β opposes the age-dependent elevations of brain copper and iron. Journal of Biological Chemistry 2002 277 47 44670 44676 2-s2.0-0037160028 10.1074/jbc.M204379200 (Pubitemid 36159056)
111. Bellingham S. A., Ciccotosto G. D., Needham B. E., Fodero L. R., White A. R., Masters C. L., Cappai R., Camakaris J., Gene knockout of amyloid precursor protein and amyloid precursor-like protein-2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts. Journal of Neurochemistry 2004 91 2 423 428 2-s2.0-5444235015 10.1111/j.1471-4159.2004. 02731.x (Pubitemid 39363441)
112. White A. R., Reyes R., Mercer J. F. B., Camakaris J., Zheng H., Bush A. I., Multhaup G., Beyreuther K., Masters C. L., Cappai R., Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Research 1999 842 2 439 444 2-s2.0-0032830357 10.1016/S0006-8993(99)01861-2 (Pubitemid 29475178)
113. Acevedo K. M., Hung Y. H., Dalziel A. H., Li Q.-X., Laughton K., Wikhe K., Rembach A., Roberts B., Masters C. L., Bush A. I., Camakaris J., Copper promotes the trafficking of the amyloid precursor protein. Journal of Biological Chemistry 2011 286 10 8252 8262 2-s2.0-79953137657 10.1074/jbc.M110.128512
114. Bolognin S., Messori L., Zatta P., Metal ion physiopathology in neurodegenerative disorders. NeuroMolecular Medicine 2009 11 4 223 238 2-s2.0-72949104344 10.1007/s12017-009-8102-1
115. Cherny R. A., Atwood C. S., Xilinas M. E., Gray D. N., Jones W. D., McLean C. A., Barnham K. J., Volitakis I., Fraser F. W., Kim Y.-S., Huang X., Goldstein L. E., Moir R. D., Lim J. T., Beyreuther K., Zheng H., Tanzi R. E., Masters C. L., Bush A. I., Treatment with a copper-zinc chelator markedly and rapidly inhibits β -amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 2001 30 3 665 676 2-s2.0-0034964390 10.1016/S0896-6273(01)00317-8 (Pubitemid 32607332)
116. Ritchie C. W., Bush A. I., Mackinnon A., Macfarlane S., Mastwyk M., MacGregor L., Kiers L., Cherny R., Li Q.-X., Tammer A., Carrington D., Mavros C., Volitakis I., Xilinas M., Ames D., Davis S., Beyreuther K., Tanzi R. E., Masters C. L., Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A β amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Archives of Neurology 2003 60 12 1685 1691 2-s2.0-10744224267 10.1001/archneur.60.12.1685 (Pubitemid 37521621)
117. Zhao B., Wan L., Metal metabolic homeostasis disruption and early initiation of mechanism for Alzheimer's disease. Progress in Biochemistry and Biophysics 2012 39 756 763
118. Iqbal K., Liu F., Gong C.-X., del Alonso A. C., Grundke-Iqbal I., Mechanisms of tau-induced neurodegeneration. Acta Neuropathologica 2009 118 1 53 69 2-s2.0-67349142329 10.1007/s00401-009-0486-3
119. Billingsley M. L., Kincaid R. L., Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochemical Journal 1997 323 3 577 591 2-s2.0-0031007546 (Pubitemid 27202326)
120. Zheng W.-H., Bastianetto S., Mennicken F., Ma W., Kar S., Amyloid β peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience 2002 115 1 201 211 2-s2.0-0037110601 10.1016/S0306-4522(02)00404-9 (Pubitemid 35232701)
121. Lewis J., Dickson D. W., Lin W.-L., Chisholm L., Corral A., Jones G., Yen S.-H., Sahara N., Skipper L., Yager D., Eckman C., Hardy J., Hutton M., McGowan E., Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 2001 293 5534 1487 1491 2-s2.0-17944382037
122. Götz J., Chen F., Van Dorpe J., Nitsch R. M., Formation of neurofibrillary tangles in P301L tau transgenic mice induced by A β 42 fibrils. Science 2001 293 5534 1491 1495 2-s2.0-0035943436 10.1126/science. 1062097 (Pubitemid 32807681)
123. Stamer K., Vogel R., Thies E., Mandelkow E., Mandelkow E.-M., Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. Journal of Cell Biology 2002 156 6 1051 1063 2-s2.0-0037128935 10.1083/jcb.200108057 (Pubitemid 34839854)
124. Dias-Santagata D., Fulga T. A., Duttaroy A., Feany M. B., Oxidative stress mediates tau-induced neurodegeneration in Drosophila. Journal of Clinical Investigation 2007 117 1 236 245 2-s2.0-33846080531 10.1172/JCI28769 (Pubitemid 46055207)
125. Cente M., Filipcik P., Pevalova M., Novak M., Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy. European Journal of Neuroscience 2006 24 4 1085 1090 2-s2.0-33747606218 10.1111/j.1460-9568.2006.04986.x (Pubitemid 44268139)
126. Cente M., Filipcik P., Mandakova S., Zilka N., Krajciova G., Novak M., Expression of a truncated human tau protein induces aqueous-phase free radicals in a rat model of tauopathy: implications for targeted antioxidative therapy. Journal of Alzheimer's Disease 2009 17 4 913 920 2-s2.0-68949145828 10.3233/JAD-2009-1107
127. Yoshiyama Y., Higuchi M., Zhang B., Huang S.-M., Iwata N., Saido T., Maeda J., Suhara T., Trojanowski J. Q., Lee V. M.-Y., Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007 53 3 337 351 2-s2.0-33846538660 10.1016/j.neuron.2007.01.010 (Pubitemid 46161268)
128. David D. C., Hauptmann S., Scherping I., Schuessel K., Keil U., Rizzu P., Ravid R., Dröse S., Brandt U., Müller W. E., Eckert A., Götz J., Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. Journal of Biological Chemistry 2005 280 25 23802 23814 2-s2.0-21244486781 10.1074/jbc.M500356200 (Pubitemid 40884866)
129. Dumont M., Stack C., Elipenahli C., Jainuddin S., Gerges M., Starkova N. N., Yang L., Starkov A. A., Beal F., Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice. The FASEB Journal 2011 25 11 4063 4072 2-s2.0-80355148410 10.1096/fj.11-186650
130. Elipenahli C., Stack C., Jainuddin S., Gerges M., Yang L., Starkov A., Beal M. F., Dumont M., Behavioral improvement after chronic administration of coenzyme Q10 in P301S transgenic mice. Journal of Alzheimer's Disease 2012 28 1 173 182 2-s2.0-84855777410 10.3233/JAD-2011-111190
131. Eckert A., Schulz K. L., Rhein V., Götz J., Convergence of amyloid- β and tau pathologies on mitochondria in vivo. Molecular Neurobiology 2010 41 2-3 107 114 2-s2.0-77955089472 10.1007/s12035-010-8109-5
132. Rhein V., Song X., Wiesner A., Ittner L. M., Baysang G., Meier F., Ozmen L., Bluethmann H., Dröse S., Brandt U., Savaskan E., Czech C., Götz J., Eckert A., Amyloid- β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proceedings of the National Academy of Sciences of the United States of America 2009 106 47 20057 20062 2-s2.0-73949142307 10.1073/pnas.0905529106
133. Gamblin T. C., King M. E., Kuret J., Berry R. W., Binder L. I., Oxidative regulation of fatty acid-induced tau polymerization. Biochemistry 2000 39 46 14203 14210 2-s2.0-0034700253 10.1021/bi001876l
134. Melov S., Adlard P. A., Morten K., Johnson F., Golden T. R., Hinerfeld D., Schilling B., Mavros C., Masters C. L., Volitakis I., Li Q.-X., Laughton K., Hubbard A., Cherny R. A., Gibson B., Bush A. I., Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS ONE 2007 2 6, article e536 2-s2.0-38849150935 10.1371/journal.pone.0000536 (Pubitemid 351194010)
135. Goedert M., Hasegawa M., Jakes R., Lawler S., Cuenda A., Cohen P., Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Letters 1997 409 1 57 62 2-s2.0-0030963035 10.1016/S0014-5793(97)00483-3 (Pubitemid 27248567)
136. Zhu X., Rottkamp C. A., Boux H., Takeda A., Perry G., Smith M. A., Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. Journal of Neuropathology and Experimental Neurology 2000 59 10 880 888 2-s2.0-0033782845